302107
Communities Putting Prevention to Work intervention costs in 44 communities
Purpose: To collect and analyze the full programmatic CPPW costs and to assess how communities allocated costs across media, access, point of decision/promotion, price, and social support and services interventions and whether costs or allocations varied by community type or size.
Methods: Quarterly data on costs were collected from the 44 CPPW communities. Program costs were estimated as spending on labor, materials/supplies, travel, partners, and program administration plus the value of in-kind donations. Communities’ total and per capita costs were estimated for each intervention implemented and compared by initiative and community size and type.
Results: Total ARRA-funded CPPW costs were $358 million, with 6% representing in-kind costs. The largest share of costs for tobacco communities went to media interventions (36%), whereas the largest share of costs for obesity communities went to access interventions (51%). Intervention costs increased with community size to a point; total costs for the largest communities were approximately $15 million.
Conclusions: The CPPW cost study is one of the first efforts to collect prospective cost data for a wide variety of community-based prevention interventions across multiple communities. CPPW communities incurred substantial costs to implement these interventions, with spending allocations varying widely across types of interventions.
Learning Areas:
Biostatistics, economicsConduct evaluation related to programs, research, and other areas of practice
Program planning
Public health or related public policy
Learning Objectives:
Describe the Communities Putting Prevention to Work (CPPW) initiative.
Explain the purpose of the study assessing the costs of the CPPW program.
Identify programmatic costs incurred by the CPPW awardees.
Keyword(s): Evaluation, Public Health Policy
Qualified on the content I am responsible for because: I an economist in RTI’s Public Health Economics Program with 10+ year of experience in the field of health economics. My research agenda includes methods for estimating the cost of disease with applications in obesity and chronic disease; program evaluation, cost and cost-effectiveness studies. I have led tasks in these topic areas for CDC, ASPE, and AHA. I have authored many publications in peer-reviewed journals.
Any relevant financial relationships? No
I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.